{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:02:39Z","timestamp":1785207759648,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Project of Health Commission of Hainan Province","award":["No.22A200272"],"award-info":[{"award-number":["No.22A200272"]}]},{"name":"Scientific Research Project of Health Commission of Hainan Province","award":["No.22A200271"],"award-info":[{"award-number":["No.22A200271"]}]},{"name":"The Hainan Provincial Natural Science Foundation of China","award":["No.825QN555"],"award-info":[{"award-number":["No.825QN555"]}]},{"name":"The Hainan Provincial Natural Science Foundation of China","award":["No.\u00a0820MS144"],"award-info":[{"award-number":["No.\u00a0820MS144"]}]},{"DOI":"10.13039\/501100013142","name":"Key Research and Development Project of Hainan Province","doi-asserted-by":"publisher","award":["No.ZDYF2022SHFZ100"],"award-info":[{"award-number":["No.ZDYF2022SHFZ100"]}],"id":[{"id":"10.13039\/501100013142","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Hainan\u00a0Provincial\u00a0Natural\u00a0Science\u00a0Foundation\u00a0of\u00a0China","award":["No.\u00a0822RC844"],"award-info":[{"award-number":["No.\u00a0822RC844"]}]},{"name":"Joint Program on Health Science & Technology Innovation of Hainan Province","award":["No.WSJK2025MS153"],"award-info":[{"award-number":["No.WSJK2025MS153"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11312-8","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T18:15:25Z","timestamp":1754072125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Surveillance and analysis of drug resistance and drug resistance levels in multidrug resistant tuberculosis on the tropical islands of China"],"prefix":"10.1186","volume":"25","author":[{"given":"Jieying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuolin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuni","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeteng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"9979","key":"11312_CR1","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. Who\u2019s new end tb strategy. Lancet. 2015;385(9979):1799\u2013801. https:\/\/doi.org\/10.1016\/S0140-6736(15)60570-0.","journal-title":"Lancet"},{"issue":"5","key":"11312_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cmi.2021.09.014","volume":"28","author":"D Liu","year":"2022","unstructured":"Liu D, Huang F, Zhang G, He W, Ou X, He P, et al. Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in china. Clin Microbiol Infect. 2022;28(5):731\u20139. https:\/\/doi.org\/10.1016\/j.cmi.2021.09.014. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=34600118%26;query_hl=1.","journal-title":"Clin Microbiol Infect"},{"key":"11312_CR3","unstructured":"Who. Global tuberculosis report 2022.\u00a02022.\u00a0Global tuberculosis report 2022. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"11312_CR4","doi-asserted-by":"publisher","unstructured":"Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010 2010;375(9728):1830\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(10)60410-2. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=20488523%26;query_hl=1.","DOI":"10.1016\/S0140-6736(10)60410-2"},{"issue":"1","key":"11312_CR5","doi-asserted-by":"publisher","first-page":"e0154321","DOI":"10.1128\/spectrum.01543-21","volume":"10","author":"W He","year":"2022","unstructured":"He W, Tan Y, Liu C, Wang Y, He P, Song Z, et al. Drug-resistant characteristics, genetic diversity, and transmission dynamics of rifampicin-resistant mycobacterium tuberculosis in hunan, china, revealed by whole-genome sequencing. Microbiol Spectr. 2022;10(1):e0154321. https:\/\/doi.org\/10.1128\/spectrum.01543-21. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=35171016%26;query_hl=1.","journal-title":"Microbiol Spectr"},{"issue":"12","key":"11312_CR6","doi-asserted-by":"publisher","first-page":"e83012","DOI":"10.1371\/journal.pone.0083012","volume":"8","author":"TG Clark","year":"2013","unstructured":"Clark TG, Mallard K, Coll F, Preston M, Assefa S, Harris D, et al. Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing. PLoS ONE. 2013;8(12):e83012. https:\/\/doi.org\/10.1371\/journal.pone.0083012. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=24349420%26;query_hl=1.","journal-title":"PLoS ONE"},{"issue":"6","key":"11312_CR7","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1128\/JCM.00298-17","volume":"55","author":"J Shea","year":"2017","unstructured":"Shea J, Halse TA, Lapierre P, Shudt M, Kohlerschmidt D, Van Roey P, et al. Comprehensive whole-genome sequencing and reporting of drug resistance profiles on clinical cases of mycobacterium tuberculosis in new york state. J Clin Microbiol. 2017;55(6):1871\u201382. https:\/\/doi.org\/10.1128\/JCM.00298-17. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=28381603%26;query_hl=1.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"11312_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13073-015-0164-0","volume":"7","author":"F Coll","year":"2015","unstructured":"Coll F, McNerney R, Preston MD, Guerra-Assuncao JA, Warry A, Hill-Cawthorne G, et al. Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Med. 2015 2015;7(1):51. https:\/\/doi.org\/10.1186\/s13073-015-0164-0. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=26019726%26;query_hl=1.","journal-title":"Genome Med"},{"issue":"10","key":"11312_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007297","volume":"14","author":"MI Groschel","year":"2018","unstructured":"Groschel MI, Walker TM, van der Werf TS, Lange C, Niemann S, Merker M. Pathogen-based precision medicine for drug-resistant tuberculosis. Plos Pathog. 2018 2018 Oct;14(10):e1007297. https:\/\/doi.org\/10.1371\/journal.ppat.1007297. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=30335850%26;query_hl=1.","journal-title":"PLoS Pathog"},{"issue":"4","key":"11312_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1473-3099(18)30132-4","volume":"18","author":"E Tagliani","year":"2018","unstructured":"Tagliani E, Cirillo DM, Kodmon C, van der Werf MJ. Euseqmytb to set standards and build capacity for whole genome sequencing for tuberculosis in the eu. Lancet Infect Dis. 2018;18(4):377. https:\/\/doi.org\/10.1016\/S1473-3099(18)30132-4.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"11312_CR11","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/cid\/ciy346","volume":"67","author":"MA Zuur","year":"2018","unstructured":"Zuur MA, Pasipanodya JG, van Soolingen D, van der Werf TS, Gumbo T, Alffenaar JC. Intermediate susceptibility dose-dependent breakpoints for high-dose rifampin, isoniazid, and pyrazinamide treatment in multidrug-resistant tuberculosis programs. Clin Infect Dis. 2018;67(11):1743\u20139. https:\/\/doi.org\/10.1093\/cid\/ciy346. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=29697766%26;query_hl=1.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"11312_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJMoa1715849","volume":"379","author":"R Colangeli","year":"2018","unstructured":"Colangeli R, Jedrey H, Kim S, Connell R, Ma S, Chippada VU, et al. Bacterial factors that predict relapse after tuberculosis therapy. N Engl J Med. 2018;379(9):823\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1715849. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=30157391%26;query_hl=1.","journal-title":"N Engl J Med"},{"key":"11312_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02175-18","author":"SM Gygli","year":"2019","unstructured":"Gygli SM, Keller PM, Ballif M, Blochliger N, Homke R, Reinhard M, et al. Whole-genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2019. https:\/\/doi.org\/10.1128\/AAC.02175-18.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"11312_CR14","doi-asserted-by":"publisher","first-page":"9676","DOI":"10.1038\/s41598-018-27962-5","volume":"8","author":"C Ruesen","year":"2018","unstructured":"Ruesen C, Riza AL, Florescu A, Chaidir L, Editoiu C, Aalders N, et al. Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in mycobacterium tuberculosis strains from romania. Sci Rep. 2018;8(1):9676. https:\/\/doi.org\/10.1038\/s41598-018-27962-5. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=29946139%26;query_hl=1.","journal-title":"Sci Rep"},{"issue":"1","key":"11312_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-021-02246-7","volume":"21","author":"L Liu","year":"2021","unstructured":"Liu L, Zhao X, Wu X, Li S, Liu B, Rajaofera M, et al. Prevalence and molecular characteristics of drug-resistant mycobacterium tuberculosis in Hainan, China: from 2014 to 2019. BMC Microbiol. 2021;21(1): 185. https:\/\/doi.org\/10.1186\/s12866-021-02246-7.","journal-title":"BMC Microbiol"},{"key":"11312_CR16","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.2147\/IDR.S423955","volume":"16","author":"J Wang","year":"2023","unstructured":"Wang J, Yu C, Xu Y, Chen Z, Qiu W, Chen S, et al. Analysis of drug-resistance characteristics and genetic diversity of multidrug-resistant tuberculosis based on whole-genome sequencing on the Hainan Island, China. Infect Drug Resist. 2023;16:5783\u201398. https:\/\/doi.org\/10.2147\/IDR.S423955.","journal-title":"Infect Drug Resist"},{"key":"11312_CR17","doi-asserted-by":"publisher","unstructured":"Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of m. Tuberculosis. Eur Respir J. 2022;60(4). https:\/\/doi.org\/10.1183\/13993003.00239-2022. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=35301246%26;query_hl=1.","DOI":"10.1183\/13993003.00239-2022"},{"issue":"3","key":"11312_CR18","doi-asserted-by":"publisher","first-page":"e0271421","DOI":"10.1128\/spectrum.02714-21","volume":"10","author":"J Li","year":"2022","unstructured":"Li J, Yang T, Hong C, Yang Z, Wu L, Gao Q, et al. Whole-genome sequencing for resistance level prediction in multidrug-resistant tuberculosis. Microbiol Spectr. 2022;10(3):e0271421. https:\/\/doi.org\/10.1128\/spectrum.02714-21. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=35658579%26;query_hl=1.","journal-title":"Microbiol Spectr"},{"key":"11312_CR19","doi-asserted-by":"publisher","unstructured":"Larsen MH, Biermann K, Tandberg S, Hsu T, Jacobs WJ. Genetic manipulation of mycobacterium tuberculosis. Curr Protoc Microbiol. 2007;Chapter 10:10A-12A. https:\/\/doi.org\/10.1002\/9780471729259.mc10a02s6. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=18770603%26;query_hl=1.","DOI":"10.1002\/9780471729259.mc10a02s6"},{"issue":"14","key":"11312_CR20","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. 2009;25(14):1754\u201360. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324.","journal-title":"Bioinformatics"},{"issue":"2","key":"11312_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, snpeff: SNPs in the genome of drosophila melanogaster strain w1118; Iso-2; Iso-3. Fly (Austin). 2012;6(2):80\u201392. https:\/\/doi.org\/10.4161\/fly.19695.","journal-title":"Fly (Austin)"},{"issue":"1","key":"11312_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13073-019-0650-x","volume":"11","author":"JE Phelan","year":"2019","unstructured":"Phelan JE, O\u2019Sullivan DM, Machado D, Ramos J, Oppong Y, Campino S, et al. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs. Genome Med. 2019;11(1):41. https:\/\/doi.org\/10.1186\/s13073-019-0650-x. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=31234910%26;query_hl=1.","journal-title":"Genome Med"},{"issue":"7","key":"11312_CR23","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1093\/molbev\/msab120","volume":"38","author":"K Tamura","year":"2021","unstructured":"Tamura K, Stecher G, Kumar S. Mega11: molecular evolutionary genetics analysis version 11. Mol Biol Evol. 2021;38(7):3022\u20137. https:\/\/doi.org\/10.1093\/molbev\/msab120.","journal-title":"Mol Biol Evol"},{"issue":"W1","key":"11312_CR24","doi-asserted-by":"publisher","first-page":"W293","DOI":"10.1093\/nar\/gkab301","volume":"49","author":"I Letunic","year":"2021","unstructured":"Letunic I, Bork P. Interactive tree of life (itol) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49(W1):W293\u20136. https:\/\/doi.org\/10.1093\/nar\/gkab301. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=33885785%26;query_hl=1.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"11312_CR25","doi-asserted-by":"publisher","first-page":"e01814","DOI":"10.1128\/mBio.01819-14","volume":"5","author":"P Miotto","year":"2014","unstructured":"Miotto P, Cabibbe AM, Feuerriegel S, Casali N, Drobniewski F, Rodionova Y, et al. Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study. MBio. 2014;5(5):e01814-e1819. https:\/\/doi.org\/10.1128\/mBio.01819-14. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=25336456%26;query_hl=1.","journal-title":"MBio"},{"issue":"1","key":"11312_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29652-3","volume":"13","author":"YX Xiao","year":"2023","unstructured":"Xiao YX, Liu KH, Lin WH, Chan TH, Jou R. Whole-genome sequencing-based analyses of drug-resistant mycobacterium tuberculosis from Taiwan. Sci Rep. 2023;13(1): 2540. https:\/\/doi.org\/10.1038\/s41598-023-29652-3. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=36781938%26;query_hl=1.","journal-title":"Sci Rep"},{"issue":"12","key":"11312_CR27","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/resp.13393","volume":"23","author":"P Miotto","year":"2018","unstructured":"Miotto P, Zhang Y, Cirillo DM, Yam WC. Drug resistance mechanisms and drug susceptibility testing for tuberculosis. Respirology. 2018;23(12):1098\u2013113. https:\/\/doi.org\/10.1111\/resp.13393. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=30189463%26;query_hl=1.","journal-title":"Respirology"},{"issue":"6","key":"11312_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213046","volume":"14","author":"CF Madrazo-Moya","year":"2019","unstructured":"Madrazo-Moya CF, Cancino-Munoz I, Cuevas-Cordoba B, Gonzalez-Covarrubias V, Barbosa-Amezcua M, Soberon X, et al. Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico. PLoS One. 2019;14(6): e0213046. https:\/\/doi.org\/10.1371\/journal.pone.0213046.","journal-title":"PLoS One"},{"issue":"10","key":"11312_CR29","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1473-3099(15)00062-6","volume":"15","author":"TM Walker","year":"2015","unstructured":"Walker TM, Kohl TA, Omar SV, Hedge J, Del OEC, Bradley P, et al. Whole-genome sequencing for prediction of mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis. 2015;15(10):1193\u2013202. https:\/\/doi.org\/10.1016\/S1473-3099(15)00062-6. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=26116186%26;query_hl=1.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"11312_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ijmm.2008.07.001","volume":"299","author":"S Srivastava","year":"2009","unstructured":"Srivastava S, Ayyagari A, Dhole TN, Nyati KK, Dwivedi SK. Emb nucleotide polymorphisms and the role of embb306 mutations in mycobacterium tuberculosis resistance to ethambutol. Int J Med Microbiol. 2009;299(4):269\u201380. https:\/\/doi.org\/10.1016\/j.ijmm.2008.07.001.","journal-title":"Int J Med Microbiol"},{"issue":"4","key":"11312_CR31","doi-asserted-by":"publisher","first-page":"e0333922","DOI":"10.1128\/spectrum.03339-22","volume":"11","author":"C Zhu","year":"2023","unstructured":"Zhu C, Yang T, Yin J, Jiang H, Takiff HE, Gao Q, et al. The global success of mycobacterium tuberculosis modern beijing family is driven by a few recently emerged strains. Microbiol Spectr. 2023;11(4):e0333922. https:\/\/doi.org\/10.1128\/spectrum.03339-22. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=37272796%26;query_hl=1.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"11312_CR32","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1080\/22221751.2020.1852891","volume":"9","author":"P Srilohasin","year":"2020","unstructured":"Srilohasin P, Prammananan T, Faksri K, Phelan JE, Suriyaphol P, Kamolwat P, et al. Genomic evidence supporting the clonal expansion of extensively drug-resistant tuberculosis bacteria belonging to a rare proto-beijing genotype. Emerg Microbes Infect. 2020;9(1):2632\u201341. https:\/\/doi.org\/10.1080\/22221751.2020.1852891. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=33205698%26;query_hl=1.","journal-title":"Emerg Microbes Infect"},{"key":"11312_CR33","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.2147\/IDR.S410828","volume":"16","author":"D Liang","year":"2023","unstructured":"Liang D, Song Z, Liang X, Qin H, Huang L, Ye J, et al. Whole genomic analysis revealed high genetic diversity and drug-resistant characteristics of mycobacterium tuberculosis in Guangxi, China. Infect Drug Resist. 2023;16:5021\u201331. https:\/\/doi.org\/10.2147\/IDR.S410828.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"11312_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s12879-022-07482-4","volume":"22","author":"W Sun","year":"2022","unstructured":"Sun W, Gui X, Wu Z, Zhang Y, Yan L. Prediction of drug resistance profile of multidrug-resistant mycobacterium tuberculosis (mdr-mtb) isolates from newly diagnosed case by whole genome sequencing (wgs): a study from a high tuberculosis burden country. Bmc Infect Dis. 2022;22(1):499.Available from: https:\/\/doi.org\/10.1186\/s12879-022-07482-4.http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=35624432%26;query_hl=1.","journal-title":"Bmc Infect Dis"},{"key":"11312_CR35","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3389\/fmicb.2019.01741","volume":"10","author":"X Chen","year":"2019","unstructured":"Chen X, He G, Wang S, Lin S, Chen J, Zhang W. Evaluation of whole-genome sequence method to diagnose resistance of 13 anti-tuberculosis drugs and characterize resistance genes in clinical multi-drug resistance mycobacterium tuberculosis isolates from china. Front Microbiol. 2019;10:1741. https:\/\/doi.org\/10.3389\/fmicb.2019.01741. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=31417530%26;query_hl=1.","journal-title":"Front Microbiol"},{"issue":"11","key":"11312_CR36","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1128\/JCM.01209-09","volume":"47","author":"A Van Deun","year":"2009","unstructured":"Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, et al. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J Clin Microbiol. 2009;47(11):3501\u20136. https:\/\/doi.org\/10.1128\/JCM.01209-09.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"11312_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5588\/ijtld.11.0178","volume":"16","author":"DA Williamson","year":"2012","unstructured":"Williamson DA, Roberts SA, Bower JE, Vaughan R, Newton S, Lowe O, et al. Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2012;16(2):216\u201320. https:\/\/doi.org\/10.5588\/ijtld.11.0178.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"11312_CR38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12879-021-06024-8","volume":"21","author":"H Zheng","year":"2021","unstructured":"Zheng H, He W, Jiao W, Xia H, Sun L, Wang S, et al. Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China. BMC Infect Dis. 2021;21(1):330. https:\/\/doi.org\/10.1186\/s12879-021-06024-8. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=33832459%26;query_hl=1.","journal-title":"BMC Infect Dis"},{"key":"11312_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00900-17","author":"Y Pang","year":"2017","unstructured":"Pang Y, Zong Z, Huo F, Jing W, Ma Y, Dong L, et al. In vitro drug susceptibility of bedaquiline, delamanid, linezolid, clofazimine, moxifloxacin, and gatifloxacin against extensively drug-resistant tuberculosis in Beijing, China. Antimicrob Agents Chemother. 2017. https:\/\/doi.org\/10.1128\/AAC.00900-17.","journal-title":"Antimicrob Agents Chemother"},{"key":"11312_CR40","doi-asserted-by":"publisher","first-page":"7587","DOI":"10.2147\/IDR.S440711","volume":"16","author":"Y Guo","year":"2023","unstructured":"Guo Y, Yang J, Wang W, Wu X, Wan B, Wang H, et al. Bedaquiline, delamanid, linezolid, clofazimine, and capreomycin mic distributions for drug resistance mycobacterium tuberculosis in shanghai, china. Infect Drug Resist. 2023;16:7587\u201395. https:\/\/doi.org\/10.2147\/IDR.S440711. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=38107433%26;query_hl=1.","journal-title":"Infect Drug Resist"},{"key":"11312_CR41","volume-title":"Who consolidated guidelines on drug-resistant tuberculosis treatment","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Who consolidated guidelines on drug-resistant tuberculosis treatment. Who guidelines approved by the guidelines review committee. Geneva: World Health Organization; 2019."},{"issue":"5","key":"11312_CR42","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1128\/AAC.00037-14","volume":"58","author":"RC Hartkoorn","year":"2014","unstructured":"Hartkoorn RC, Uplekar S, Cole ST. Cross-resistance between clofazimine and bedaquiline through upregulation of mmpl5 in mycobacterium tuberculosis. Antimicrob Agents Chemother. 2014;58(5):2979\u201381. https:\/\/doi.org\/10.1128\/AAC.00037-14.","journal-title":"Antimicrob Agents Chemother"},{"key":"11312_CR43","volume-title":"Policy guidance on drug-susceptibility testing (dst) of second-line antituberculosis drugs","author":"L Barrera","year":"2008","unstructured":"Barrera L, Cooreman E, de Dieu IJ, Drobniewski F, Duda P, Havelkova M, et al. Policy guidance on drug-susceptibility testing (dst) of second-line antituberculosis drugs. Geneva: World Health Organization; 2008."},{"issue":"3","key":"11312_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/MCP.0b013e3283452346","volume":"17","author":"J O'Grady","year":"2011","unstructured":"O\u2019Grady J, Maeurer M, Mwaba P, Kapata N, Bates M, Hoelscher M, et al. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. Curr Opin Pulm Med. 2011;17(3):134\u201341. https:\/\/doi.org\/10.1097\/MCP.0b013e3283452346. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve%26;db=pubmed%26;dopt=Abstract%26;list_uids=21415753%26;query_hl=1.","journal-title":"Curr Opin Pulm Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11312-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11312-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11312-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:32:16Z","timestamp":1757331136000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11312-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11312"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11312-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"4 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the University of the Second Affiliated Hospital of Hainan Medical University, China (No.LW2020226) and waived the requirement for informed consent.This study complies with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"973"}}